Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35750419

Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Immunother Cancer
Publication date
2022 Jun
First author
Bennani NN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Bennani NN
      type
      Author
    2. name
      Kim HJ
      type
      Author
    3. name
      Pederson LD
      type
      Author
    4. name
      Atherton PJ
      type
      Author
    5. name
      Micallef IN
      type
      Author
    6. name
      Thanarajasingam G
      type
      Author
    7. name
      Nowakowski GS
      type
      Author
    8. name
      Witzig T
      type
      Author
    9. name
      Feldman AL
      type
      Author
    10. name
      Ansell SM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Bennani NN
      type
      Author
    2. name
      Kim HJ
      type
      Author
    3. name
      Pederson LD
      type
      Author
    4. name
      Atherton PJ
      type
      Author
    5. name
      Micallef IN
      type
      Author
    6. name
      Thanarajasingam G
      type
      Author
    7. name
      Nowakowski GS
      type
      Author
    8. name
      Witzig T
      type
      Author
    9. name
      Feldman AL
      type
      Author
    10. name
      Ansell SM
      type
      Author
    bibliography ids
    1. nci-bib-3567c4875c259824b6f7e24b
    book metadata
    content sha256
    b0ba9a994336eac645588af58f4fb07ffa2ba4d29060570f83dcb31cd88de957
    document type
    citation
    dois
    1. 10.1136/jitc-2022-004984
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35750419
    immutable id
    pubmed:35750419@b0ba9a994336eac645588af58f4fb07ffa2ba4d29060570f83dcb31cd88de957
    journal
    abbreviation
    J Immunother Cancer
    issn electronic
    2051-1426
    issn print
    Source null
    issue
    6
    name
    Journal for immunotherapy of cancer
    nlm unique id
    101620585
    pages
    Source null
    volume
    10
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35750419
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      56551a9feaf87faa2a1cca52feb23b1b146aa7139eb8f01d8b58316a5ce13d44
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Jun
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      4. Clinical Trial, Phase II
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35750419/
      title
      Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression.

      Preserved source evidence · Not medical advice